European Journal of Cardio-Thoracic Surgery最新文献

{"title":"Diffuse invasion of pulmonary arterial and venous structures due to Echinococcus granulosus infection.","authors":"Yener Aydin, Hayri Ogul, Ali Bilal Ulas","doi":"10.1093/ejcts/ezaf126","DOIUrl":"10.1093/ejcts/ezaf126","url":null,"abstract":"","PeriodicalId":11938,"journal":{"name":"European Journal of Cardio-Thoracic Surgery","volume":" ","pages":""},"PeriodicalIF":3.1,"publicationDate":"2025-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143802705","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Same-day discharge for patients undergoing subxiphoid thoracoscopic thymectomy for small tumours without myasthenia gravis: a prospective, single-arm clinical trial.","authors":"Yuan-Liang Zheng, Yu-Ping Yuan, Xiao-Yong Liang, Hong-Li Liao","doi":"10.1093/ejcts/ezaf122","DOIUrl":"10.1093/ejcts/ezaf122","url":null,"abstract":"<p><strong>Objectives: </strong>Subxiphoid thoracoscopic surgery is an effective method for treating thymic tumours. We performed the first evaluation of the safety and feasibility of same-day discharge (SDD) in patients undergoing this procedure and summarized their associated clinical experience.</p><p><strong>Methods: </strong>We conducted a single-arm, single-centre prospective clinical trial. This study was registered at www.chictr.org.cn (ChiCTR2300077148). The subjects were patients with a preoperative clinical diagnosis of thymic tumour. All eligible patients underwent examinations and preparations at the preoperative preparation centre and subsequently underwent a subxiphoid thoracoscopic thymectomy. The evaluation indicators included R0 (complete resection without residual tumour) resection rate, SDD completion rate, 30-day postoperative readmission rate, number of emergency visits, perioperative complication rate, length of stay and total medical costs.</p><p><strong>Results: </strong>A total of 39 patients were enrolled between November 2023 and April 2024. All patients underwent subxiphoid thoracoscopic resection of the thymic tumours to achieve R0 resection. The completion rate of the SDD surgery was 92.3% (36/39). The perioperative complication rate was 5.6% (2/36 patients). Only 2.8% (1/36) of the patients were readmitted within 1 month of an emergency visit due to pneumothorax. The median length of stay was 11 h (interquartile range 10-14), and the median total medical cost was 19 400 renminbi (interquartile range 18 500-21 100).</p><p><strong>Conclusions: </strong>The SDD procedure may be safe and feasible for selected patients undergoing subxiphoid thoracoscopic thymectomy, based on a small sample size. Large-scale studies are needed to confirm these preliminary findings.</p>","PeriodicalId":11938,"journal":{"name":"European Journal of Cardio-Thoracic Surgery","volume":" ","pages":""},"PeriodicalIF":3.1,"publicationDate":"2025-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12007883/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143763523","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Reconstruction of the isolated left vertebral artery in total aortic arch replacement for type A aortic dissection via a single upper right hemisternotomy approach.","authors":"Lu Wang, Yu-Guang Ge, Zhong-Lu Yang, Yu Liu, Lin Xia, Zhi-Shuo Liu, Hui Jiang","doi":"10.1093/ejcts/ezaf121","DOIUrl":"10.1093/ejcts/ezaf121","url":null,"abstract":"<p><strong>Objectives: </strong>The isolated left vertebral artery (ILVA) is a rare congenital abnormality of the branches of the aortic arch. Its presence can influence both the surgical procedure and the prognosis of total aortic arch replacement. The goal of this study was to assess the early postoperative outcomes of ILVA reconstruction performed during total aortic arch replacement via a single upper right hemisternotomy approach.</p><p><strong>Methods: </strong>From October 2018 to March 2024, patients diagnosed with type A aortic dissection who underwent total aortic arch replacement via a single upper right hemisternotomy at the General Hospital of the Northern Theater Command were included. Based on the presence of ILVA, the patients were divided into the ILVA group and the control group. Patients in the ILVA group underwent intraoperative ILVA reconstruction, and relevant perioperative clinical data were collected and analysed. Inverse probability of treatment weighting was applied to balance the preoperative baseline data.</p><p><strong>Results: </strong>A total of 516 patients were included in the study. Of these, 34 patients were in the ILVA group, which included 27 males (79.4%) with a mean age of 48.9 ± 12.9 years; the remaining 482 patients were assigned to the control group, which included 360 males (74.7%) with a mean age of 50.5 ± 10.9 years. Following adjustment using the inverse probability of treatment weighting, the incidence of paraplegia was significantly lower in the ILVA group than in the control group (0% vs 2.14%, P = 0.003). Furthermore, the incidence of stroke (3.38% vs 6.55%, P = 0.354) and of in-hospital death (3.23% vs 5.58%, P = 0.454) was similar in both groups.</p><p><strong>Conclusions: </strong>The research indicates that ILVA reconstruction during total aortic arch replacement via a single upper right hemisternotomy effectively preserved ILVA patency and resulted in excellent early outcomes. Statistically, the incidence of postoperative paraplegia was significantly lower compared to the that in the control group, and no significant differences were observed in deaths or other complications between the 2 groups.</p><p><strong>Clinical registration number: </strong>The study was approved by the Ethics Committee of the General Hospital of the Northern Theater Command, Shenyang City, China [Y(2024)188].</p>","PeriodicalId":11938,"journal":{"name":"European Journal of Cardio-Thoracic Surgery","volume":" ","pages":""},"PeriodicalIF":3.1,"publicationDate":"2025-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143763521","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Reply to Papazisi et al.","authors":"Yoshikazu Ono, Shin Yajima, Tomoyuki Fujita, Satsuki Fukushima","doi":"10.1093/ejcts/ezaf096","DOIUrl":"https://doi.org/10.1093/ejcts/ezaf096","url":null,"abstract":"","PeriodicalId":11938,"journal":{"name":"European Journal of Cardio-Thoracic Surgery","volume":"67 4","pages":""},"PeriodicalIF":3.1,"publicationDate":"2025-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143970655","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Long-term outcomes after bioprosthetic tricuspid valve replacement: a multicenter study.","authors":"Antonio Piperata, Jef Van den Eynde, Mateo Marin-Cuartas, Giacomo Bortolussi, Petr Fila, Tim Walter, Mehmet Cahit Sarıcaoğlu, Jan Gofus, Bilkhu Rajdeep, Michel Pompeu Sá, Fabrizio Rosati, Manuela De la Cuesta, Elisa Gastino, Besart Cuko, Julien Ternacle, Carlo de Vincentiis, Martin Czerny, Ahmet Rüçhan Akar, Gianluca Lucchese, Basel Ramlawi, Michael A Borger, Thomas Modine","doi":"10.1093/ejcts/ezaf107","DOIUrl":"10.1093/ejcts/ezaf107","url":null,"abstract":"<p><strong>Objectives: </strong>Long-term evidence about bioprosthetic tricuspid valve replacement is scarce. This study aims to investigate the long-term clinical outcomes of patients who underwent tricuspid valve replacement with bioprostheses.</p><p><strong>Methods: </strong>This multicentre retrospective study included patients from 10 high-volume centres in 7 different countries, who underwent tricuspid valve replacement with bioprostheses. Echocardiographic and clinical data were reviewed. Long-term outcomes were investigated using Kaplan-Meier estimates, Cox regression, and competing risk analysis.</p><p><strong>Results: </strong>Of 675 patients, isolated tricuspid valve replacement was performed in 358 patients (53%), while 317 (47%) underwent concomitant procedures. Between these 2 groups, patients who underwent combined procedures reported a significantly higher incidence of infection, atrioventricular block, multi-organ failure, longer intensive care unit and hospital stay and higher 30-day mortality over patients who underwent isolated procedure. The overall 30-day mortality occurred in 70 patients (10.4%) [46 (14.6%) combined vs 24 (6.74%) isolated, P = 0.001]. During the follow-up, there was a continuous rate of attrition due to death, with cumulative incidences of death at 5, 10 and 15 years being 27.2%, 46.2% and 60.6%, respectively. In contrast, the risk of reintervention starts to significantly increase after 10 years of follow-up, with cumulative incidences of reintervention being 6.1%, 10.8% and 23.3%, respectively. Freedom from tricuspid valve reintervention, pacemaker implantation, tricuspid valve endocarditis and major thromboembolic events at 15 years were 56.5%, 77.3%, 84.0% and 86.4%, respectively.</p><p><strong>Conclusions: </strong>Tricuspid valve replacement with bioprostheses is an effective treatment for valvular disease, despite being associated with relatively high early and long-term mortality. However, the risk of structural valve degeneration rises significantly after 10 years.</p>","PeriodicalId":11938,"journal":{"name":"European Journal of Cardio-Thoracic Surgery","volume":" ","pages":""},"PeriodicalIF":3.1,"publicationDate":"2025-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143700057","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Corrigendum to: Anatomical evaluation of a novel echocardiography based tricuspid valve classification in 60 hearts from body donors.","authors":"","doi":"10.1093/ejcts/ezaf123","DOIUrl":"10.1093/ejcts/ezaf123","url":null,"abstract":"","PeriodicalId":11938,"journal":{"name":"European Journal of Cardio-Thoracic Surgery","volume":"67 4","pages":""},"PeriodicalIF":3.0,"publicationDate":"2025-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143976196","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Letter: the effect of virtual reality on postoperative anxiety and pain in patients following cardiac surgery: a randomized controlled trial.","authors":"Huihong Xie, Fei Gao, Xiaochun Zheng","doi":"10.1093/ejcts/ezaf090","DOIUrl":"10.1093/ejcts/ezaf090","url":null,"abstract":"","PeriodicalId":11938,"journal":{"name":"European Journal of Cardio-Thoracic Surgery","volume":" ","pages":""},"PeriodicalIF":3.1,"publicationDate":"2025-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143673615","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Steroids in aortic dissection surgery.","authors":"Domenico Paparella, Richard P Whitlock","doi":"10.1093/ejcts/ezaf116","DOIUrl":"10.1093/ejcts/ezaf116","url":null,"abstract":"","PeriodicalId":11938,"journal":{"name":"European Journal of Cardio-Thoracic Surgery","volume":" ","pages":""},"PeriodicalIF":3.1,"publicationDate":"2025-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143742684","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Implications of pacemaker implantation after aortic valve surgery for endocarditis: a nationwide study†.","authors":"Lisa O F Bearpark, Michael Dismorr, Anders Franco-Cereceda, Ulrik Sartipy, Natalie Glaser","doi":"10.1093/ejcts/ezaf125","DOIUrl":"10.1093/ejcts/ezaf125","url":null,"abstract":"<p><strong>Objectives: </strong>Infective endocarditis (IE) is associated with a high risk of atrioventricular block and surgery adds to the risk of receiving a permanent pacemaker. The clinical impact of pacemaker implantation in IE patients is insufficiently studied. Our objective was to analyse long-term clinical outcomes in patients who receive a permanent pacemaker after IE surgery.</p><p><strong>Methods: </strong>We conducted a nationwide observational cohort study, including all patients undergoing surgery for aortic valve IE in Sweden 1997-2022. The exposure group was patients who received a permanent pacemaker within 30 days of surgery. We used inverse probability of treatment weighting to account for inter-group differences and flexible parametric models to estimate hazards and cumulative incidences. Outcomes were all-cause mortality, heart failure and reinfection in the prosthetic valve.</p><p><strong>Results: </strong>Among 2175 patients who underwent surgery for aortic valve endocarditis, 168 (8%) received a permanent pacemaker. The mean age was 59 years; 18% were female. During a mean follow-up of 8.0 years (maximum 26 years), 822 patients (38%) died. At 15 years, the cumulative incidence of all-cause mortality was 60% versus 50% in the pacemaker versus the no pacemaker group; for heart failure, it was 21% versus 16%. We found no association of pacemaker implantation with mortality [hazard ratio (HR) 1.17; 95% confidence interval (CI) 0.86-1.58], heart failure (HR 1.42; 95% CI 0.89-2.29) or reinfection (HR 0.85; 95% CI 0.50-1.45).</p><p><strong>Conclusions: </strong>Pacemaker implantation after surgery for aortic valve IE is common but was not associated with an increased risk of death, heart failure or reinfection. Although pacemaker need suggests more advanced disease, these results show that lifesaving surgery is not importantly jeopardised by the need for a pacemaker.</p>","PeriodicalId":11938,"journal":{"name":"European Journal of Cardio-Thoracic Surgery","volume":" ","pages":""},"PeriodicalIF":3.1,"publicationDate":"2025-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12033029/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143802711","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Femoral vessel cannulation strategies in minimally invasive cardiac surgery: single Perclose ProGlide versus open cut-down†.","authors":"Majd Ismail, Dilara Merve Berberoglu Aydin, Jang-Sun Lee, Markus Schönburg, Efstratios Charitos, Yeong-Hoon Choi, Oliver Joannis Liakopoulos","doi":"10.1093/ejcts/ezaf118","DOIUrl":"10.1093/ejcts/ezaf118","url":null,"abstract":"<p><strong>Objectives: </strong>Surgical cut-down is commonly used for femoral cannulation in minimally invasive cardiac surgery, but is associated with higher rates of wound healing disorders. Percutaneous cannulation using vascular closure devices offers a less invasive alternative with potentially fewer complications. The aim of this study was to assess the feasibility and safety of using a single ProGlide system for primary access-site closure in comparison with surgical cut-down. Additionally, we analysed the learning curve for adopting this strategy.</p><p><strong>Methods: </strong>A retrospective analysis was conducted on 753 patients who underwent minimally invasive cardiac surgery at our centre between January 2018 and February 2024. Femoral access was achieved via open cut-down in 377 patients and percutaneous cannulation using a single ProGlide system in 376. The percutaneous cohort was categorized into 2 subgroups: early era (2020-2021, N = 102) versus late era (2022-2024, N = 274). The primary end-point was late access-site-related complications, while the secondary end-point was device failure requiring open femoral revision.</p><p><strong>Results: </strong>Access-site complications including lymph fistula, healing disorders were significantly higher in the open cut-down group compared to the percutaneous group (lymph fistula: 10.6% cut-down vs 0.3% percutaneous, P = 0.004, healing disorders: 3.4% cut-down vs 0% vascular closure device, P < 0.001). The success rate of a single vascular closure device strategy improved from 65.7% in the early era to 91.6% in the late era (P < 0.001), with fewer device failures (2.9% vs 11.7%; P = 0.001).</p><p><strong>Conclusions: </strong>Percutaneous cannulation using single ProGlide is observed as a safe and feasible alternative to open femoral cut-down and showed excellent results after an initial learning curve.</p>","PeriodicalId":11938,"journal":{"name":"European Journal of Cardio-Thoracic Surgery","volume":" ","pages":""},"PeriodicalIF":3.1,"publicationDate":"2025-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12000529/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143779385","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}